"Dopamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Descriptor ID |
D004298
|
MeSH Number(s) |
D02.092.211.215.311.342 D02.092.311.342
|
Concept/Terms |
Dopamine- Dopamine
- 4-(2-Aminoethyl)-1,2-benzenediol
- Hydroxytyramine
- 3,4-Dihydroxyphenethylamine
- 3,4 Dihydroxyphenethylamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine".
Below are MeSH descriptors whose meaning is more specific than "Dopamine".
This graph shows the total number of publications written about "Dopamine" by people in this website by year, and whether "Dopamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 9 | 6 | 15 |
1995 | 9 | 5 | 14 |
1996 | 4 | 4 | 8 |
1997 | 8 | 3 | 11 |
1998 | 3 | 4 | 7 |
1999 | 8 | 1 | 9 |
2000 | 3 | 4 | 7 |
2001 | 3 | 2 | 5 |
2002 | 1 | 1 | 2 |
2003 | 2 | 4 | 6 |
2004 | 3 | 6 | 9 |
2005 | 5 | 3 | 8 |
2006 | 7 | 5 | 12 |
2007 | 8 | 8 | 16 |
2008 | 9 | 6 | 15 |
2009 | 8 | 5 | 13 |
2010 | 5 | 4 | 9 |
2011 | 3 | 1 | 4 |
2012 | 4 | 3 | 7 |
2013 | 3 | 1 | 4 |
2014 | 2 | 3 | 5 |
2015 | 3 | 3 | 6 |
2016 | 4 | 2 | 6 |
2017 | 3 | 2 | 5 |
2018 | 1 | 4 | 5 |
2019 | 0 | 5 | 5 |
2020 | 0 | 1 | 1 |
2021 | 3 | 3 | 6 |
2022 | 1 | 6 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine" by people in Profiles.
-
Changing Cerebral Blood Flow, Glucose Metabolism, and Dopamine Binding Through Transcranial Magnetic Stimulation: A Systematic Review of Transcranial Magnetic Stimulation-Positron Emission Tomography Literature. Pharmacol Rev. 2022 10; 74(4):918-932.
-
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PLoS One. 2022; 17(9):e0275182.
-
Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex. Neuropsychopharmacology. 2022 09; 47(10):1816-1825.
-
Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt-1 knockout mice. J Neurochem. 2022 06; 161(5):435-452.
-
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 10; 47(11):1953-1960.
-
Changes in striatal dopamine release, sleep, and behavior during spontaneous ?-9-tetrahydrocannabinol abstinence in male and female mice. Neuropsychopharmacology. 2022 07; 47(8):1537-1549.
-
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait. J Parkinsons Dis. 2022; 12(4):1241-1250.
-
Adolescent Intermittent Ethanol (AIE) Enhances the Dopaminergic Response to Ethanol within the Mesolimbic Pathway during Adulthood: Alterations in Cholinergic/Dopaminergic Genes Expression in the Nucleus Accumbens Shell. Int J Mol Sci. 2021 Oct 29; 22(21).
-
Executive function and dopamine response in Parkinson's disease freezing of gait. Parkinsonism Relat Disord. 2021 11; 92:46-50.
-
The rostromedial tegmental (RMTg) "brake" on dopamine and behavior: A decade of progress but also much unfinished work. Neuropharmacology. 2021 10 15; 198:108763.